Global Skin Cancer Diagnostics Market Size, Share & Trends Analysis Report By Type, By Test Type, By End-use, By Regional Outlook and Forecast, 2024

List of Tables

The Global Skin Cancer Diagnostics Market size is expected to reach $12.8 billion by 2031, rising at a market growth of 5.3% CAGR during the forecast period.

A combination of high skin cancer prevalence, advanced healthcare infrastructure, and strong government support drives the market in this region. Skin cancer, particularly non-melanoma and melanoma is highly prevalent in the United States, with millions of cases diagnosed annually. This widespread incidence necessitates extensive diagnostic services. Advanced healthcare systems in North America, particularly in the United States and Canada, are equipped with state-of-the-art diagnostic tools such as dermatoscopes, confocal microscopes, and AI-enhanced imaging systems, which enhance diagnostic accuracy and efficiency. Thus, the North America region acquired 37% revenue share in the market 2023.

The proportion of people diagnosed with melanoma around the world has been gradually climbing, which has led to a rise in the demand for cutting-edge diagnostic tools and technology. Globally, 132,000 melanoma skin cancers and 2 to 3 million non-melanoma skin cancers are diagnosed annually, according to the World Health Organization (WHO).

Additionally, it is projected that the incidence of skin cancer will increase, particularly among those who are 50 years of age or older, as the global population advances in age. Consequently, the demand for more comprehensive diagnostic methods and healthcare services will increase.

However, advanced equipment such as dermatoscopes, confocal microscopes, and sophisticated imaging systems represent cutting-edge technology for accurate and early skin cancer detection. However, the development and manufacturing of these tools involve substantial investment, which is reflected in their market prices.

Type Outlook

Based on cancer type, the market is characterized into melanoma and non-melanoma. The non-melanoma segment garnered 72% revenue share in the market in 2023. Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), the two most prevalent forms of skin cancer, are the primary factors driving the segment.

Test Type Outlook

On the basis of test type, the market is classified into dermatoscopy, skin biopsy, lymph node biopsy, imaging tests, and others. The imaging tests segment recorded 27% revenue share in the market in 2023.

End-use Outlook

By end-use, the market is divided into hospital & clinics, laboratories, and others. The hospital & clinics segment witnessed 51% revenue share in the market in 2023. Patients who require medical attention for skin issues, including potential skin cancer, are served by hospitals and clinics as their primary sites of care.

Reginal Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment acquired 23% revenue share in the skin cancer diagnostics market in 2023. Countries like Australia face high skin cancer rates due to significant UV exposure while emerging markets such as China, India, and Japan are witnessing increasing skin cancer cases.

List of Key Companies Profiled

Castle Biosciences, Inc.
Bausch Health Companies, Inc. (DermTech, Inc.)
Canfield Scientific, Inc.
DermaSensor, Inc.
F. Hoffmann-La Roche Ltd.
NeoGenomics, Inc.
Quest Diagnostics Incorporated.
Digital Diagnostics, Inc. (3Derm Systems, Inc.)
FotoFinder Systems GmbH
Veriskin Inc

Global Skin Cancer Diagnostics Market Report Segmentation

By Type

Non-Melanoma
Melanoma

By Test Type

Skin Biopsy
Imaging Tests
Dermatoscopy
Lymph Node Biopsy
Others

By End-use

Hospital & Clinics
Laboratories
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Skin Cancer Diagnostics Market, by Type
- 1.4.2 Global Skin Cancer Diagnostics Market, by Test Type
- 1.4.3 Global Skin Cancer Diagnostics Market, by End-use
- 1.4.4 Global Skin Cancer Diagnostics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Global Skin Cancer Diagnostics Market by Type

4.1 Global Non-Melanoma Market by Region
4.2 Global Melanoma Market by Region

Chapter 5. Global Skin Cancer Diagnostics Market by Test Type

5.1 Global Skin Biopsy Market by Region
5.2 Global Imaging Tests Market by Region
5.3 Global Dermatoscopy Market by Region
5.4 Global Lymph Node Biopsy Market by Region
5.5 Global Others Market by Region

Chapter 6. Global Skin Cancer Diagnostics Market by End-use

6.1 Global Hospital & Clinics Market by Region
6.2 Global Laboratories Market by Region
6.3 Global Others Market by Region

Chapter 7. Global Skin Cancer Diagnostics Market by Region

7.1 North America Skin Cancer Diagnostics Market
- 7.1.1 North America Skin Cancer Diagnostics Market by Type
  - 7.1.1.1 North America Non-Melanoma Market by Country
  - 7.1.1.2 North America Melanoma Market by Country
- 7.1.2 North America Skin Cancer Diagnostics Market by Test Type
  - 7.1.2.1 North America Skin Biopsy Market by Country
  - 7.1.2.2 North America Imaging Tests Market by Country
  - 7.1.2.3 North America Dermatoscopy Market by Country
  - 7.1.2.4 North America Lymph Node Biopsy Market by Country
  - 7.1.2.5 North America Others Market by Country
- 7.1.3 North America Skin Cancer Diagnostics Market by End-use
  - 7.1.3.1 North America Hospital & Clinics Market by Country
  - 7.1.3.2 North America Laboratories Market by Country
  - 7.1.3.3 North America Others Market by Country
- 7.1.4 North America Skin Cancer Diagnostics Market by Country
  - 7.1.4.1 US Skin Cancer Diagnostics Market
    - 7.1.4.1.1 US Skin Cancer Diagnostics Market by Type
    - 7.1.4.1.2 US Skin Cancer Diagnostics Market by Test Type
    - 7.1.4.1.3 US Skin Cancer Diagnostics Market by End-use
  - 7.1.4.2 Canada Skin Cancer Diagnostics Market
    - 7.1.4.2.1 Canada Skin Cancer Diagnostics Market by Type
    - 7.1.4.2.2 Canada Skin Cancer Diagnostics Market by Test Type
    - 7.1.4.2.3 Canada Skin Cancer Diagnostics Market by End-use
  - 7.1.4.3 Mexico Skin Cancer Diagnostics Market
    - 7.1.4.3.1 Mexico Skin Cancer Diagnostics Market by Type
    - 7.1.4.3.2 Mexico Skin Cancer Diagnostics Market by Test Type
    - 7.1.4.3.3 Mexico Skin Cancer Diagnostics Market by End-use
  - 7.1.4.4 Rest of North America Skin Cancer Diagnostics Market
    - 7.1.4.4.1 Rest of North America Skin Cancer Diagnostics Market by Type
    - 7.1.4.4.2 Rest of North America Skin Cancer Diagnostics Market by Test Type
    - 7.1.4.4.3 Rest of North America Skin Cancer Diagnostics Market by End-use
7.2 Europe Skin Cancer Diagnostics Market
- 7.2.1 Europe Skin Cancer Diagnostics Market by Type
  - 7.2.1.1 Europe Non-Melanoma Market by Country
  - 7.2.1.2 Europe Melanoma Market by Country
- 7.2.2 Europe Skin Cancer Diagnostics Market by Test Type
  - 7.2.2.1 Europe Skin Biopsy Market by Country
  - 7.2.2.2 Europe Imaging Tests Market by Country
  - 7.2.2.3 Europe Dermatoscopy Market by Country
  - 7.2.2.4 Europe Lymph Node Biopsy Market by Country
  - 7.2.2.5 Europe Others Market by Country
- 7.2.3 Europe Skin Cancer Diagnostics Market by End-use
  - 7.2.3.1 Europe Hospital & Clinics Market by Country
  - 7.2.3.2 Europe Laboratories Market by Country
  - 7.2.3.3 Europe Others Market by Country
- 7.2.4 Europe Skin Cancer Diagnostics Market by Country
  - 7.2.4.1 Germany Skin Cancer Diagnostics Market
    - 7.2.4.1.1 Germany Skin Cancer Diagnostics Market by Type
    - 7.2.4.1.2 Germany Skin Cancer Diagnostics Market by Test Type
    - 7.2.4.1.3 Germany Skin Cancer Diagnostics Market by End-use
  - 7.2.4.2 UK Skin Cancer Diagnostics Market
    - 7.2.4.2.1 UK Skin Cancer Diagnostics Market by Type
    - 7.2.4.2.2 UK Skin Cancer Diagnostics Market by Test Type
    - 7.2.4.2.3 UK Skin Cancer Diagnostics Market by End-use
  - 7.2.4.3 France Skin Cancer Diagnostics Market
    - 7.2.4.3.1 France Skin Cancer Diagnostics Market by Type
    - 7.2.4.3.2 France Skin Cancer Diagnostics Market by Test Type
    - 7.2.4.3.3 France Skin Cancer Diagnostics Market by End-use
  - 7.2.4.4 Russia Skin Cancer Diagnostics Market
    - 7.2.4.4.1 Russia Skin Cancer Diagnostics Market by Type
    - 7.2.4.4.2 Russia Skin Cancer Diagnostics Market by Test Type
    - 7.2.4.4.3 Russia Skin Cancer Diagnostics Market by End-use
  - 7.2.4.5 Spain Skin Cancer Diagnostics Market
    - 7.2.4.5.1 Spain Skin Cancer Diagnostics Market by Type
    - 7.2.4.5.2 Spain Skin Cancer Diagnostics Market by Test Type
    - 7.2.4.5.3 Spain Skin Cancer Diagnostics Market by End-use
  - 7.2.4.6 Italy Skin Cancer Diagnostics Market
    - 7.2.4.6.1 Italy Skin Cancer Diagnostics Market by Type
    - 7.2.4.6.2 Italy Skin Cancer Diagnostics Market by Test Type
    - 7.2.4.6.3 Italy Skin Cancer Diagnostics Market by End-use
  - 7.2.4.7 Rest of Europe Skin Cancer Diagnostics Market
    - 7.2.4.7.1 Rest of Europe Skin Cancer Diagnostics Market by Type
    - 7.2.4.7.2 Rest of Europe Skin Cancer Diagnostics Market by Test Type
    - 7.2.4.7.3 Rest of Europe Skin Cancer Diagnostics Market by End-use
7.3 Asia Pacific Skin Cancer Diagnostics Market
- 7.3.1 Asia Pacific Skin Cancer Diagnostics Market by Type
  - 7.3.1.1 Asia Pacific Non-Melanoma Market by Country
  - 7.3.1.2 Asia Pacific Melanoma Market by Country
- 7.3.2 Asia Pacific Skin Cancer Diagnostics Market by Test Type
  - 7.3.2.1 Asia Pacific Skin Biopsy Market by Country
  - 7.3.2.2 Asia Pacific Imaging Tests Market by Country
  - 7.3.2.3 Asia Pacific Dermatoscopy Market by Country
  - 7.3.2.4 Asia Pacific Lymph Node Biopsy Market by Country
  - 7.3.2.5 Asia Pacific Others Market by Country
- 7.3.3 Asia Pacific Skin Cancer Diagnostics Market by End-use
  - 7.3.3.1 Asia Pacific Hospital & Clinics Market by Country
  - 7.3.3.2 Asia Pacific Laboratories Market by Country
  - 7.3.3.3 Asia Pacific Others Market by Country
- 7.3.4 Asia Pacific Skin Cancer Diagnostics Market by Country
  - 7.3.4.1 China Skin Cancer Diagnostics Market
    - 7.3.4.1.1 China Skin Cancer Diagnostics Market by Type
    - 7.3.4.1.2 China Skin Cancer Diagnostics Market by Test Type
    - 7.3.4.1.3 China Skin Cancer Diagnostics Market by End-use
  - 7.3.4.2 Japan Skin Cancer Diagnostics Market
    - 7.3.4.2.1 Japan Skin Cancer Diagnostics Market by Type
    - 7.3.4.2.2 Japan Skin Cancer Diagnostics Market by Test Type
    - 7.3.4.2.3 Japan Skin Cancer Diagnostics Market by End-use
  - 7.3.4.3 India Skin Cancer Diagnostics Market
    - 7.3.4.3.1 India Skin Cancer Diagnostics Market by Type
    - 7.3.4.3.2 India Skin Cancer Diagnostics Market by Test Type
    - 7.3.4.3.3 India Skin Cancer Diagnostics Market by End-use
  - 7.3.4.4 South Korea Skin Cancer Diagnostics Market
    - 7.3.4.4.1 South Korea Skin Cancer Diagnostics Market by Type
    - 7.3.4.4.2 South Korea Skin Cancer Diagnostics Market by Test Type
    - 7.3.4.4.3 South Korea Skin Cancer Diagnostics Market by End-use
  - 7.3.4.5 Singapore Skin Cancer Diagnostics Market
    - 7.3.4.5.1 Singapore Skin Cancer Diagnostics Market by Type
    - 7.3.4.5.2 Singapore Skin Cancer Diagnostics Market by Test Type
    - 7.3.4.5.3 Singapore Skin Cancer Diagnostics Market by End-use
  - 7.3.4.6 Malaysia Skin Cancer Diagnostics Market
    - 7.3.4.6.1 Malaysia Skin Cancer Diagnostics Market by Type
    - 7.3.4.6.2 Malaysia Skin Cancer Diagnostics Market by Test Type
    - 7.3.4.6.3 Malaysia Skin Cancer Diagnostics Market by End-use
  - 7.3.4.7 Rest of Asia Pacific Skin Cancer Diagnostics Market
    - 7.3.4.7.1 Rest of Asia Pacific Skin Cancer Diagnostics Market by Type
    - 7.3.4.7.2 Rest of Asia Pacific Skin Cancer Diagnostics Market by Test Type
    - 7.3.4.7.3 Rest of Asia Pacific Skin Cancer Diagnostics Market by End-use
7.4 LAMEA Skin Cancer Diagnostics Market
- 7.4.1 LAMEA Skin Cancer Diagnostics Market by Type
  - 7.4.1.1 LAMEA Non-Melanoma Market by Country
  - 7.4.1.2 LAMEA Melanoma Market by Country
- 7.4.2 LAMEA Skin Cancer Diagnostics Market by Test Type
  - 7.4.2.1 LAMEA Skin Biopsy Market by Country
  - 7.4.2.2 LAMEA Imaging Tests Market by Country
  - 7.4.2.3 LAMEA Dermatoscopy Market by Country
  - 7.4.2.4 LAMEA Lymph Node Biopsy Market by Country
  - 7.4.2.5 LAMEA Others Market by Country
- 7.4.3 LAMEA Skin Cancer Diagnostics Market by End-use
  - 7.4.3.1 LAMEA Hospital & Clinics Market by Country
  - 7.4.3.2 LAMEA Laboratories Market by Country
  - 7.4.3.3 LAMEA Others Market by Country
- 7.4.4 LAMEA Skin Cancer Diagnostics Market by Country
  - 7.4.4.1 Brazil Skin Cancer Diagnostics Market
    - 7.4.4.1.1 Brazil Skin Cancer Diagnostics Market by Type
    - 7.4.4.1.2 Brazil Skin Cancer Diagnostics Market by Test Type
    - 7.4.4.1.3 Brazil Skin Cancer Diagnostics Market by End-use
  - 7.4.4.2 Argentina Skin Cancer Diagnostics Market
    - 7.4.4.2.1 Argentina Skin Cancer Diagnostics Market by Type
    - 7.4.4.2.2 Argentina Skin Cancer Diagnostics Market by Test Type
    - 7.4.4.2.3 Argentina Skin Cancer Diagnostics Market by End-use
  - 7.4.4.3 UAE Skin Cancer Diagnostics Market
    - 7.4.4.3.1 UAE Skin Cancer Diagnostics Market by Type
    - 7.4.4.3.2 UAE Skin Cancer Diagnostics Market by Test Type
    - 7.4.4.3.3 UAE Skin Cancer Diagnostics Market by End-use
  - 7.4.4.4 Saudi Arabia Skin Cancer Diagnostics Market
    - 7.4.4.4.1 Saudi Arabia Skin Cancer Diagnostics Market by Type
    - 7.4.4.4.2 Saudi Arabia Skin Cancer Diagnostics Market by Test Type
    - 7.4.4.4.3 Saudi Arabia Skin Cancer Diagnostics Market by End-use
  - 7.4.4.5 South Africa Skin Cancer Diagnostics Market
    - 7.4.4.5.1 South Africa Skin Cancer Diagnostics Market by Type
    - 7.4.4.5.2 South Africa Skin Cancer Diagnostics Market by Test Type
    - 7.4.4.5.3 South Africa Skin Cancer Diagnostics Market by End-use
  - 7.4.4.6 Nigeria Skin Cancer Diagnostics Market
    - 7.4.4.6.1 Nigeria Skin Cancer Diagnostics Market by Type
    - 7.4.4.6.2 Nigeria Skin Cancer Diagnostics Market by Test Type
    - 7.4.4.6.3 Nigeria Skin Cancer Diagnostics Market by End-use
  - 7.4.4.7 Rest of LAMEA Skin Cancer Diagnostics Market
    - 7.4.4.7.1 Rest of LAMEA Skin Cancer Diagnostics Market by Type
    - 7.4.4.7.2 Rest of LAMEA Skin Cancer Diagnostics Market by Test Type
    - 7.4.4.7.3 Rest of LAMEA Skin Cancer Diagnostics Market by End-use

Chapter 8. Company Profiles

8.1 Castle Biosciences, Inc.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Research & Development Expenses
- 8.1.4 Recent strategies and developments:
  - 8.1.4.1 Product Launches and Product Expansions:
  - 8.1.4.2 Acquisition and Mergers:
- 8.1.5 SWOT Analysis
8.2 Bausch Health Companies, Inc.(DermTech, Inc.)
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
8.3 Canfield Scientific, Inc.
- 8.3.1 Company Overview
- 8.3.2 SWOT Analysis
8.4 DermaSensor, Inc.
- 8.4.1 Company Overview
- 8.4.2 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expense
- 8.5.5 Recent strategies and developments:
  - 8.5.5.1 Partnerships, Collaborations, and Agreements:
- 8.5.6 SWOT Analysis
8.6 Neogenomics, Inc.
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental Analysis
- 8.6.4 Research & Development Expenses
- 8.6.5 SWOT Analysis
8.7 Quest Diagnostics Incorporated
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental Analysis
- 8.7.4 Recent strategies and developments:
  - 8.7.4.1 Partnerships, Collaborations, and Agreements:
  - 8.7.4.2 Acquisition and Mergers:
- 8.7.5 SWOT Analysis
8.8 Digital Diagnostics, Inc.(3Derm Systems, Inc.)
- 8.8.1 Company Overview
8.9 FotoFinder Systems GmbH
- 8.9.1 Company Overview
- 8.9.2 SWOT Analysis
8.10. VERISKIN INC.
- 8.10.1 Company Overview
- 8.10.2 SWOT Analysis

Chapter 9. Winning Imperatives for Skin Cancer Diagnostics Market

LIST OF TABLES

TABLE 1 Global Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 2 Global Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 3 Global Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 4 Global Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 5 Global Non-Melanoma Market by Region, 2020 - 2023, USD Million
TABLE 6 Global Non-Melanoma Market by Region, 2024 - 2031, USD Million
TABLE 7 Global Melanoma Market by Region, 2020 - 2023, USD Million
TABLE 8 Global Melanoma Market by Region, 2024 - 2031, USD Million
TABLE 9 Global Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 10 Global Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 11 Global Skin Biopsy Market by Region, 2020 - 2023, USD Million
TABLE 12 Global Skin Biopsy Market by Region, 2024 - 2031, USD Million
TABLE 13 Global Imaging Tests Market by Region, 2020 - 2023, USD Million
TABLE 14 Global Imaging Tests Market by Region, 2024 - 2031, USD Million
TABLE 15 Global Dermatoscopy Market by Region, 2020 - 2023, USD Million
TABLE 16 Global Dermatoscopy Market by Region, 2024 - 2031, USD Million
TABLE 17 Global Lymph Node Biopsy Market by Region, 2020 - 2023, USD Million
TABLE 18 Global Lymph Node Biopsy Market by Region, 2024 - 2031, USD Million
TABLE 19 Global Others Market by Region, 2020 - 2023, USD Million
TABLE 20 Global Others Market by Region, 2024 - 2031, USD Million
TABLE 21 Global Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 22 Global Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 23 Global Hospital & Clinics Market by Region, 2020 - 2023, USD Million
TABLE 24 Global Hospital & Clinics Market by Region, 2024 - 2031, USD Million
TABLE 25 Global Laboratories Market by Region, 2020 - 2023, USD Million
TABLE 26 Global Laboratories Market by Region, 2024 - 2031, USD Million
TABLE 27 Global Others Market by Region, 2020 - 2023, USD Million
TABLE 28 Global Others Market by Region, 2024 - 2031, USD Million
TABLE 29 Global Skin Cancer Diagnostics Market by Region, 2020 - 2023, USD Million
TABLE 30 Global Skin Cancer Diagnostics Market by Region, 2024 - 2031, USD Million
TABLE 31 North America Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 32 North America Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 33 North America Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 34 North America Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 35 North America Non-Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 36 North America Non-Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 37 North America Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 38 North America Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 39 North America Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 40 North America Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 41 North America Skin Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 42 North America Skin Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 43 North America Imaging Tests Market by Country, 2020 - 2023, USD Million
TABLE 44 North America Imaging Tests Market by Country, 2024 - 2031, USD Million
TABLE 45 North America Dermatoscopy Market by Country, 2020 - 2023, USD Million
TABLE 46 North America Dermatoscopy Market by Country, 2024 - 2031, USD Million
TABLE 47 North America Lymph Node Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 48 North America Lymph Node Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 49 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 50 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 51 North America Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 52 North America Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 53 North America Hospital & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 54 North America Hospital & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 55 North America Laboratories Market by Country, 2020 - 2023, USD Million
TABLE 56 North America Laboratories Market by Country, 2024 - 2031, USD Million
TABLE 57 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 58 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 59 North America Skin Cancer Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 60 North America Skin Cancer Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 61 US Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 62 US Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 63 US Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 64 US Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 65 US Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 66 US Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 67 US Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 68 US Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 69 Canada Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 70 Canada Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 71 Canada Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 72 Canada Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 73 Canada Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 74 Canada Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 75 Canada Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 76 Canada Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 77 Mexico Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 78 Mexico Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 79 Mexico Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 80 Mexico Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 81 Mexico Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 82 Mexico Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 83 Mexico Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 84 Mexico Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 85 Rest of North America Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 86 Rest of North America Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 87 Rest of North America Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 88 Rest of North America Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 89 Rest of North America Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 90 Rest of North America Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 91 Rest of North America Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 92 Rest of North America Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 93 Europe Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 94 Europe Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 95 Europe Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 96 Europe Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 97 Europe Non-Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 98 Europe Non-Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 99 Europe Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 100 Europe Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 101 Europe Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 102 Europe Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 103 Europe Skin Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 104 Europe Skin Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 105 Europe Imaging Tests Market by Country, 2020 - 2023, USD Million
TABLE 106 Europe Imaging Tests Market by Country, 2024 - 2031, USD Million
TABLE 107 Europe Dermatoscopy Market by Country, 2020 - 2023, USD Million
TABLE 108 Europe Dermatoscopy Market by Country, 2024 - 2031, USD Million
TABLE 109 Europe Lymph Node Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 110 Europe Lymph Node Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 111 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 112 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 113 Europe Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 114 Europe Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 115 Europe Hospital & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 116 Europe Hospital & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 117 Europe Laboratories Market by Country, 2020 - 2023, USD Million
TABLE 118 Europe Laboratories Market by Country, 2024 - 2031, USD Million
TABLE 119 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 120 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 121 Europe Skin Cancer Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 122 Europe Skin Cancer Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 123 Germany Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 124 Germany Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 125 Germany Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 126 Germany Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 127 Germany Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 128 Germany Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 129 Germany Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 130 Germany Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 131 UK Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 132 UK Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 133 UK Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 134 UK Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 135 UK Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 136 UK Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 137 UK Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 138 UK Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 139 France Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 140 France Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 141 France Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 142 France Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 143 France Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 144 France Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 145 France Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 146 France Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 147 Russia Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 148 Russia Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 149 Russia Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 150 Russia Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 151 Russia Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 152 Russia Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 153 Russia Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 154 Russia Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 155 Spain Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 156 Spain Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 157 Spain Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 158 Spain Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 159 Spain Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 160 Spain Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 161 Spain Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 162 Spain Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 163 Italy Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 164 Italy Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 165 Italy Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 166 Italy Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 167 Italy Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 168 Italy Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 169 Italy Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 170 Italy Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 171 Rest of Europe Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 172 Rest of Europe Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 173 Rest of Europe Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 174 Rest of Europe Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 175 Rest of Europe Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 176 Rest of Europe Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 177 Rest of Europe Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 178 Rest of Europe Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 179 Asia Pacific Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 180 Asia Pacific Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 181 Asia Pacific Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 182 Asia Pacific Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 183 Asia Pacific Non-Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 184 Asia Pacific Non-Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 185 Asia Pacific Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 186 Asia Pacific Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 187 Asia Pacific Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 188 Asia Pacific Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 189 Asia Pacific Skin Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 190 Asia Pacific Skin Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 191 Asia Pacific Imaging Tests Market by Country, 2020 - 2023, USD Million
TABLE 192 Asia Pacific Imaging Tests Market by Country, 2024 - 2031, USD Million
TABLE 193 Asia Pacific Dermatoscopy Market by Country, 2020 - 2023, USD Million
TABLE 194 Asia Pacific Dermatoscopy Market by Country, 2024 - 2031, USD Million
TABLE 195 Asia Pacific Lymph Node Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 196 Asia Pacific Lymph Node Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 197 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 198 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 199 Asia Pacific Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 200 Asia Pacific Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 201 Asia Pacific Hospital & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 202 Asia Pacific Hospital & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 203 Asia Pacific Laboratories Market by Country, 2020 - 2023, USD Million
TABLE 204 Asia Pacific Laboratories Market by Country, 2024 - 2031, USD Million
TABLE 205 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 206 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 207 Asia Pacific Skin Cancer Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 208 Asia Pacific Skin Cancer Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 209 China Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 210 China Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 211 China Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 212 China Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 213 China Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 214 China Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 215 China Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 216 China Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 217 Japan Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 218 Japan Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 219 Japan Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 220 Japan Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 221 Japan Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 222 Japan Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 223 Japan Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 224 Japan Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 225 India Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 226 India Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 227 India Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 228 India Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 229 India Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 230 India Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 231 India Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 232 India Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 233 South Korea Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 234 South Korea Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 235 South Korea Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 236 South Korea Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 237 South Korea Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 238 South Korea Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 239 South Korea Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 240 South Korea Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 241 Singapore Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 242 Singapore Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 243 Singapore Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 244 Singapore Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 245 Singapore Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 246 Singapore Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 247 Singapore Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 248 Singapore Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 249 Malaysia Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 250 Malaysia Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 251 Malaysia Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 252 Malaysia Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 253 Malaysia Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 254 Malaysia Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 255 Malaysia Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 256 Malaysia Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 257 Rest of Asia Pacific Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 258 Rest of Asia Pacific Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 259 Rest of Asia Pacific Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 260 Rest of Asia Pacific Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 261 Rest of Asia Pacific Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 262 Rest of Asia Pacific Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 263 Rest of Asia Pacific Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 264 Rest of Asia Pacific Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 265 LAMEA Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 266 LAMEA Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 267 LAMEA Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 268 LAMEA Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 269 LAMEA Non-Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 270 LAMEA Non-Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 271 LAMEA Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 272 LAMEA Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 273 LAMEA Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 274 LAMEA Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 275 LAMEA Skin Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 276 LAMEA Skin Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 277 LAMEA Imaging Tests Market by Country, 2020 - 2023, USD Million
TABLE 278 LAMEA Imaging Tests Market by Country, 2024 - 2031, USD Million
TABLE 279 LAMEA Dermatoscopy Market by Country, 2020 - 2023, USD Million
TABLE 280 LAMEA Dermatoscopy Market by Country, 2024 - 2031, USD Million
TABLE 281 LAMEA Lymph Node Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 282 LAMEA Lymph Node Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 283 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 284 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 285 LAMEA Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 286 LAMEA Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 287 LAMEA Hospital & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 288 LAMEA Hospital & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 289 LAMEA Laboratories Market by Country, 2020 - 2023, USD Million
TABLE 290 LAMEA Laboratories Market by Country, 2024 - 2031, USD Million
TABLE 291 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 292 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 293 LAMEA Skin Cancer Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 294 LAMEA Skin Cancer Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 295 Brazil Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 296 Brazil Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 297 Brazil Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 298 Brazil Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 299 Brazil Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 300 Brazil Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 301 Brazil Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 302 Brazil Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 303 Argentina Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 304 Argentina Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 305 Argentina Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 306 Argentina Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 307 Argentina Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 308 Argentina Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 309 Argentina Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 310 Argentina Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 311 UAE Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 312 UAE Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 313 UAE Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 314 UAE Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 315 UAE Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 316 UAE Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 317 UAE Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 318 UAE Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 319 Saudi Arabia Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 320 Saudi Arabia Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 321 Saudi Arabia Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 322 Saudi Arabia Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 323 Saudi Arabia Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 324 Saudi Arabia Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 325 Saudi Arabia Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 326 Saudi Arabia Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 327 South Africa Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 328 South Africa Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 329 South Africa Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 330 South Africa Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 331 South Africa Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 332 South Africa Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 333 South Africa Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 334 South Africa Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million

TABLE 335 Nigeria Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 336 Nigeria Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 337 Nigeria Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 338 Nigeria Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 339 Nigeria Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 340 Nigeria Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 341 Nigeria Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 342 Nigeria Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 343 Rest of LAMEA Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 344 Rest of LAMEA Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 345 Rest of LAMEA Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 346 Rest of LAMEA Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 347 Rest of LAMEA Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 348 Rest of LAMEA Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 349 Rest of LAMEA Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 350 Rest of LAMEA Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 351 Key Information - Castle Biosciences, Inc.
TABLE 352 key information - Bausch Health Companies, Inc.
TABLE 353 Key Information - Canfield Scientific, Inc.
TABLE 354 Key Information - Dermasensor, Inc.
TABLE 355 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 356 Key Information - neogenomics, inc.
TABLE 357 Key information - Quest Diagnostics Incorporated
TABLE 358 Key Information - Digital Diagnostics, Inc.
TABLE 359 Key Information - FotoFinder Systems GmbH
TABLE 360 Key Information - Veriskin Inc.

Global Skin Cancer Diagnostics Market Size, Share & Trends Analysis Report By Type, By Test Type, By End-use, By Regional Outlook and Forecast, 2024 - 2031

Description

Table of Contents